AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $388,705 | +104.6% | 42,435 | +80.6% | 0.01% | -8.3% |
| Q4 2021 | $190,000 | +187.9% | 23,500 | +116.8% | 0.01% | +140.0% |
| Q2 2018 | $66,000 | -80.1% | 10,839 | -76.1% | 0.01% | -78.3% |
| Q1 2018 | $331,000 | +180.5% | 45,406 | +215.8% | 0.02% | +76.9% |
| Q4 2017 | $118,000 | -68.9% | 14,376 | -60.3% | 0.01% | -86.5% |
| Q3 2017 | $380,000 | +13.1% | 36,218 | +18.7% | 0.10% | +4.3% |
| Q2 2017 | $336,000 | +48.7% | 30,500 | +30.7% | 0.09% | +217.2% |
| Q1 2017 | $226,000 | – | 23,331 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |